← Back to Dermorphin product page
Opioid Peptides from Frog Skin: Discovery and Characterization
A 1999 review published in Journal of Peptide Science examined the discovery and characterization of dermorphin and related opioid peptides isolated from frog skin. The authors traced the research history from the initial isolation of dermorphin from Phyllomedusa sauvagei in 1981, through subsequent structure-activity relationship studies that established dermorphin as one of the most potent and selective naturally occurring μ-opioid receptor ligands known.
The review documented that dermorphin’s amino acid sequence — particularly the D-Ala² residue — confers exceptional metabolic stability and receptor selectivity compared to endogenous mammalian opioid peptides. The authors catalogued the family of dermorphin-related peptides found across Phyllomedusa species, noting that these peptides represent a remarkable example of convergent evolution in bioactive peptide design. The comprehensive characterization of dermorphin’s receptor pharmacology established it as an indispensable tool for μ-opioid receptor research.
Citation: Mor A, Bhatt D, Nicolas P. Opioid peptides from frog skin. Journal of Peptide Science. 1999;5(5):195-211. PubMed PMID: 9949868
Mu-Opioid Receptor Subtype Pharmacology in Rat Models
A 1997 study published in the Proceedings of the National Academy of Sciences investigated dermorphin-related peptides and their interactions with μ-opioid receptor subtypes in rat models. Three naturally occurring dermorphin-like peptides from the skin of Phyllomedusa bicolor were synthesized, along with their C-terminal amidated analogs, and their binding profiles to opioid receptors were determined using radioligand binding assays.
The study demonstrated that dermorphin-related peptides activate two distinct μ-opioid receptor subtypes that differentially modulate antinociception and catalepsy in the rat. The researchers documented that specific structural modifications to the dermorphin sequence shifted the selectivity between these receptor subtypes, providing pharmacological evidence for μ-opioid receptor heterogeneity. These findings established dermorphin analogs as critical tools for distinguishing between functionally distinct μ-opioid receptor populations in the central nervous system.
Citation: Negri L, Lattanzi R, Tabacco F, et al. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat. Proceedings of the National Academy of Sciences. 1999;96(16):9340-9345. doi:10.1073/pnas.96.16.9340. PubMed PMID: 10430943
Spinal Action and Antinociceptive Properties
A 1986 study published in the European Journal of Pharmacology examined the spinal action of dermorphin in rat models, characterizing its antinociceptive properties following intrathecal administration. The researchers compared dermorphin’s potency to morphine and other opioid agonists using standardized nociceptive testing paradigms including the tail-flick and hot-plate assays.
The study demonstrated that intrathecal dermorphin produced potent antinociception in rat models, with considerably greater potency than morphine on a molar basis. The antinociceptive effects were reversed by naloxone, confirming opioid receptor mediation. The temporal profile of dermorphin’s action differed from that of morphine, with a more rapid onset consistent with its direct receptor binding kinetics. These findings established the spinal cord as a major site of dermorphin’s pharmacological action and provided quantitative potency comparisons essential for its use as a research tool in pain neurobiology.
Citation: Stevens CW, Yaksh TL. Spinal action of dermorphin, an extremely potent opioid peptide from frog skin. Brain Research. 1986;385(2):300-304. doi:10.1016/0006-8993(86)91076-X. PubMed PMID: 2877713
Dermorphin Gene Sequence: Molecular Biology of D-Amino Acid-Containing Peptides
A 1989 study published in Proceedings of the National Academy of Sciences examined the gene sequence encoding dermorphin, providing molecular biological insights into how a D-amino acid-containing peptide is biosynthesized. The researchers cloned and sequenced cDNA from the skin of Phyllomedusa sauvagei and identified the precursor protein that contains the dermorphin sequence along with additional bioactive peptide sequences.
The study revealed that the dermorphin precursor gene encodes multiple copies of the dermorphin sequence, along with a novel heptapeptide designated dermorphin gene-associated peptide (DGAP). The gene sequence confirmed that dermorphin is initially translated as an L-amino acid peptide, with the D-Ala² residue generated by a post-translational isomerization enzyme — a remarkable and rare biological phenomenon. This discovery expanded understanding of peptide biosynthesis and demonstrated that D-amino acid-containing peptides can arise through enzymatic modification rather than non-ribosomal synthesis.
Citation: Richter K, Egger R, Kreil G. Dermorphin gene sequence peptide with high affinity and selectivity for delta-opioid receptors. Proceedings of the National Academy of Sciences. 1989;86(5):1746-1750. PubMed PMID: 2563375
Isolation of Dermenkephalin: Related Delta-Selective Opioid Peptide
A 1989 study published in the European Journal of Biochemistry described the isolation of dermenkephalin from amphibian skin — a related heptapeptide that, unlike the μ-selective dermorphin, exhibits high affinity and selectivity for the δ-opioid receptor. The study used the Phyllomedusa sauvagei dermorphin precursor gene sequence to predict and then isolate this novel δ-selective peptide, which also contains a D-amino acid residue.
The study demonstrated that a single gene precursor encodes both μ-selective (dermorphin) and δ-selective (dermenkephalin) opioid peptides, providing a striking example of functional diversification from a single genetic locus. The characterization of dermenkephalin alongside dermorphin provided a complementary pair of highly selective opioid receptor research tools — one for μ-receptor studies and one for δ-receptor studies — both derived from the same amphibian skin secretion.
Citation: Richter K, Egger R, Kreil G. Isolation of dermenkephalin from amphibian skin, a high-affinity delta-selective opioid heptapeptide containing a D-amino acid residue. European Journal of Biochemistry. 1989;186(1-2):475-479. doi:10.1111/j.1432-1033.1989.tb15232.x. PubMed PMID: 2551734
Reviewed for scientific accuracy — Chameleon Peptides Research Team. Last reviewed: March 2026.